Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Shares Up 6.5 Percent On News of Japanese Distribution Deal

NEW YORK, May 3 (GenomeWeb News) - Shares in CombiMatrix were up 6.5 percent, or $.16, at $2.63 in mid-afternoon trading one day after the company said that Inter Medical will distribute its microarrays in Japan

 

As GenomeWeb News reported yesterday, CombiMatrix's parent company Acacia Research said the non-exclusive agreement calls for Inter Medical to market, sell, and service CombiMatrix's CustomArray products in the country.

 

Inter Medical imports and distributes medical products from European, US, and other companies in Japan, including Axon scanners from Molecular Devices.

 

CombiMatrix said it will continue to seek additional distribution deals, both in the USand internationally.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.